Advanced Cancers and FGFR Genetic Alterations

1 clinical trials · Condition

Record	Firm	Date
Expanded Access Program (EAP) for Participants With Advanced Cancers and Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations Who Have Exhausted All Treatment Options (NCT03825484)	Janssen Scientific Affairs, LLC

Every clearance here is in the API, with alerts when new ones post.